These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5801290)

  • 1. [Growth of solid Ehrlich ascites tumors in mice following BCG immunization].
    Gillissen G; Nehring G
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 139(3):206-10. PubMed ID: 5801290
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of nonspecific immune stimulation with BCG and polidin on the Ehrlich ascites tumor growth.
    Todoruţiu-Papilian C; Daicoviciu D; Mulea R; Rişcă R
    Morphol Embryol (Bucur); 1985; 31(3):217-25. PubMed ID: 2931598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian influence on the immunization of mice with live Bacillus Calmette-Guérin (BCG) and subsequent challenge with Ehrlich ascites carcinoma.
    Tsai TH; Burns RE; Scheving LE
    Chronobiologia; 1979; 6(3):187-201. PubMed ID: 520096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of BCG on the survival of mice following intraperitoneal administration of Ehrlich ascites tumor cells].
    Jakóbisiak M; Kossakowska AE; Zelechowska M; Kamiński M
    Med Dosw Mikrobiol; 1974; 26(3):235-40. PubMed ID: 4409404
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunostimulating effect of Listeria monocytogenes, BCG and their biologically active extracts on the model of mouse ascites tumors.
    Mára M; Nedvĕdová V; Miková Z; Hyncica V
    Neoplasma; 1979; 26(6):703-10. PubMed ID: 120515
    [No Abstract]   [Full Text] [Related]  

  • 6. Specific and non-specific immunotherapy of Ehrlich Ascites Carcinoma in mice.
    Jakóbisiak M; Kańtoch M; Lasek W; Dobaczewska H; Obłakowski P
    Folia Biol (Krakow); 1982; 30(3-4):91-7. PubMed ID: 7166197
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunotherapy of Ehrlich ascites tumor in mice].
    Jakóbisiak M
    Pol Arch Med Wewn; 1980 May; 63(5):503-9. PubMed ID: 7413475
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistance and susceptibility to tumours. IV. The temporary survival and rejection of the Ehrlich ascites carcinoma in xenogeneic hosts.
    Dvorák R; Karásek J
    Neoplasma; 1970; 17(4):361-71. PubMed ID: 4394171
    [No Abstract]   [Full Text] [Related]  

  • 9. Morphological changes in BFU hairless mice injected by homologous tumours -- Ehrlich's and Brno carcinomas.
    Dvoŕák R; Chlumecký J; Bĕlar A
    Scr Med (Brno); 1965; 38(6):285-94. PubMed ID: 5849734
    [No Abstract]   [Full Text] [Related]  

  • 10. [The modelling of the growth of Ehrlich carcinoma and teratoma T-36 with ascitic fluid and tumor-cell dialysate].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):193-5. PubMed ID: 1467492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ascitic versus solid growth of Ehrlich ascites tumor influenced by immunological factors.
    Culo F; Allegretti N; Marusić M
    Oncology; 1978; 35(1):15-21. PubMed ID: 625393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.
    Carry PJ; Prescott DM; Ogilvie GK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2139-40. PubMed ID: 445411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of ascitic fluid on the growth of Ehrlich tumor and Lewis carcinoma].
    Donenko FV; Kabieva AO; Moroz LV
    Biull Eksp Biol Med; 1992 Jul; 114(8):191-3. PubMed ID: 1467491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
    Sur P; Roy DK
    Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
    [No Abstract]   [Full Text] [Related]  

  • 15. Survival of host mice and induced resistance to transplantable ascites tumors.
    Kimura Y; Tanino T
    Jpn J Exp Med; 1966 Aug; 36(4):371-405. PubMed ID: 4291054
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the immunobiologic properties of Ehrlich ascites carcinoma under the effect of suspension from normal rat tissues. I. Heterotransplantation of Ehrlich ascites carcinoma].
    Novikov DK
    Tsitologiia; 1965; 7(3):420-3. PubMed ID: 5879870
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamics of growth and regression of Ehrlich ascites carcinoma transplanted intraperitoneally in rats.
    Janik P; Dabrowski M; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):717-23. PubMed ID: 5957993
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
    Bregula U; Slowikowska G; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematologic changes in rats inoculated intraperitoneally with Ehrlich ascites carcinoma.
    Dabrowska B; Janik P; Radwański Z; Dux K
    Arch Immunol Ther Exp (Warsz); 1966; 14(6):724-9. PubMed ID: 5957994
    [No Abstract]   [Full Text] [Related]  

  • 20. Circadian rhythm in survivorship after removal of Ehrlich ascites tumor.
    Brown HR
    Transplantation; 1974 Mar; 17(3):322-3. PubMed ID: 4814198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.